nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Angina unstable—Metformin—polycystic ovary syndrome	0.0229	0.0675	CcSEcCtD
Capecitabine—Tonsillitis—Metformin—polycystic ovary syndrome	0.0229	0.0675	CcSEcCtD
Capecitabine—CDA—endometrium—polycystic ovary syndrome	0.0171	0.0565	CbGeAlD
Capecitabine—DPYD—uterus—polycystic ovary syndrome	0.0163	0.0541	CbGeAlD
Capecitabine—CYP2C9—urine—polycystic ovary syndrome	0.0163	0.0539	CbGeAlD
Capecitabine—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0162	0.0477	CcSEcCtD
Capecitabine—DPYD—adipose tissue—polycystic ovary syndrome	0.016	0.0529	CbGeAlD
Capecitabine—CDA—adipose tissue—polycystic ovary syndrome	0.0154	0.0509	CbGeAlD
Capecitabine—DPYD—adrenal gland—polycystic ovary syndrome	0.0143	0.0474	CbGeAlD
Capecitabine—Tooth abscess—Metformin—polycystic ovary syndrome	0.0139	0.0408	CcSEcCtD
Capecitabine—CDA—adrenal gland—polycystic ovary syndrome	0.0138	0.0456	CbGeAlD
Capecitabine—DPYD—female gonad—polycystic ovary syndrome	0.0134	0.0442	CbGeAlD
Capecitabine—CDA—vagina—polycystic ovary syndrome	0.0128	0.0423	CbGeAlD
Capecitabine—CDA—endocrine gland—polycystic ovary syndrome	0.012	0.0396	CbGeAlD
Capecitabine—TYMP—adrenal cortex—polycystic ovary syndrome	0.0115	0.0381	CbGeAlD
Capecitabine—TYMP—endometrium—polycystic ovary syndrome	0.0103	0.034	CbGeAlD
Capecitabine—TYMP—uterus—polycystic ovary syndrome	0.00947	0.0313	CbGeAlD
Capecitabine—TYMP—pituitary gland—polycystic ovary syndrome	0.0093	0.0308	CbGeAlD
Capecitabine—TYMP—adipose tissue—polycystic ovary syndrome	0.00926	0.0306	CbGeAlD
Capecitabine—Respiratory distress—Metformin—polycystic ovary syndrome	0.00912	0.0268	CcSEcCtD
Capecitabine—Nail disorder—Metformin—polycystic ovary syndrome	0.00894	0.0263	CcSEcCtD
Capecitabine—TYMS—endometrium—polycystic ovary syndrome	0.00881	0.0292	CbGeAlD
Capecitabine—TYMP—adrenal gland—polycystic ovary syndrome	0.00831	0.0275	CbGeAlD
Capecitabine—CES1—adipose tissue—polycystic ovary syndrome	0.00799	0.0265	CbGeAlD
Capecitabine—TYMS—adipose tissue—polycystic ovary syndrome	0.00794	0.0263	CbGeAlD
Capecitabine—TYMP—female gonad—polycystic ovary syndrome	0.00774	0.0256	CbGeAlD
Capecitabine—TYMP—vagina—polycystic ovary syndrome	0.0077	0.0255	CbGeAlD
Capecitabine—Fungal infection—Metformin—polycystic ovary syndrome	0.00751	0.0221	CcSEcCtD
Capecitabine—TYMP—endocrine gland—polycystic ovary syndrome	0.0072	0.0238	CbGeAlD
Capecitabine—CES1—adrenal gland—polycystic ovary syndrome	0.00717	0.0237	CbGeAlD
Capecitabine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00715	0.021	CcSEcCtD
Capecitabine—TYMS—adrenal gland—polycystic ovary syndrome	0.00713	0.0236	CbGeAlD
Capecitabine—Rigors—Metformin—polycystic ovary syndrome	0.0071	0.0209	CcSEcCtD
Capecitabine—CES1—female gonad—polycystic ovary syndrome	0.00668	0.0221	CbGeAlD
Capecitabine—TYMS—female gonad—polycystic ovary syndrome	0.00664	0.022	CbGeAlD
Capecitabine—Contusion—Metformin—polycystic ovary syndrome	0.00664	0.0195	CcSEcCtD
Capecitabine—TYMS—vagina—polycystic ovary syndrome	0.0066	0.0219	CbGeAlD
Capecitabine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00655	0.0193	CcSEcCtD
Capecitabine—CES1—endocrine gland—polycystic ovary syndrome	0.00622	0.0206	CbGeAlD
Capecitabine—TYMS—endocrine gland—polycystic ovary syndrome	0.00618	0.0205	CbGeAlD
Capecitabine—Neuropathy—Metformin—polycystic ovary syndrome	0.00544	0.016	CcSEcCtD
Capecitabine—Ear pain—Metformin—polycystic ovary syndrome	0.00493	0.0145	CcSEcCtD
Capecitabine—Renal impairment—Metformin—polycystic ovary syndrome	0.00442	0.013	CcSEcCtD
Capecitabine—Lethargy—Metformin—polycystic ovary syndrome	0.00429	0.0126	CcSEcCtD
Capecitabine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00421	0.0124	CcSEcCtD
Capecitabine—Migraine—Metformin—polycystic ovary syndrome	0.00414	0.0122	CcSEcCtD
Capecitabine—Dehydration—Metformin—polycystic ovary syndrome	0.00391	0.0115	CcSEcCtD
Capecitabine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00388	0.0114	CcSEcCtD
Capecitabine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00384	0.0113	CcSEcCtD
Capecitabine—Breast disorder—Metformin—polycystic ovary syndrome	0.0038	0.0112	CcSEcCtD
Capecitabine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00376	0.0111	CcSEcCtD
Capecitabine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00366	0.0108	CcSEcCtD
Capecitabine—Influenza—Metformin—polycystic ovary syndrome	0.00364	0.0107	CcSEcCtD
Capecitabine—Sweating increased—Metformin—polycystic ovary syndrome	0.00354	0.0104	CcSEcCtD
Capecitabine—Angina pectoris—Metformin—polycystic ovary syndrome	0.00354	0.0104	CcSEcCtD
Capecitabine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00349	0.0103	CcSEcCtD
Capecitabine—Neutropenia—Metformin—polycystic ovary syndrome	0.0034	0.01	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00338	0.00994	CcSEcCtD
Capecitabine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00324	0.00954	CcSEcCtD
Capecitabine—Infestation—Metformin—polycystic ovary syndrome	0.00324	0.00954	CcSEcCtD
Capecitabine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00318	0.00935	CcSEcCtD
Capecitabine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00307	0.00902	CcSEcCtD
Capecitabine—Bradycardia—Metformin—polycystic ovary syndrome	0.00296	0.00872	CcSEcCtD
Capecitabine—Rhinitis—Metformin—polycystic ovary syndrome	0.00292	0.00858	CcSEcCtD
Capecitabine—Hepatitis—Metformin—polycystic ovary syndrome	0.00291	0.00856	CcSEcCtD
Capecitabine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0029	0.00852	CcSEcCtD
Capecitabine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00287	0.00843	CcSEcCtD
Capecitabine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00286	0.00841	CcSEcCtD
Capecitabine—Eye disorder—Metformin—polycystic ovary syndrome	0.00272	0.008	CcSEcCtD
Capecitabine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0027	0.00795	CcSEcCtD
Capecitabine—Flushing—Metformin—polycystic ovary syndrome	0.0027	0.00795	CcSEcCtD
Capecitabine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.0027	0.00893	CbGeAlD
Capecitabine—Angiopathy—Metformin—polycystic ovary syndrome	0.00264	0.00777	CcSEcCtD
Capecitabine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00263	0.00773	CcSEcCtD
Capecitabine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00262	0.00772	CcSEcCtD
Capecitabine—Chills—Metformin—polycystic ovary syndrome	0.00261	0.00768	CcSEcCtD
Capecitabine—Erythema—Metformin—polycystic ovary syndrome	0.00253	0.00745	CcSEcCtD
Capecitabine—Malnutrition—Metformin—polycystic ovary syndrome	0.00253	0.00745	CcSEcCtD
Capecitabine—Flatulence—Metformin—polycystic ovary syndrome	0.0025	0.00734	CcSEcCtD
Capecitabine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00248	0.0073	CcSEcCtD
Capecitabine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00244	0.00717	CcSEcCtD
Capecitabine—Vision blurred—Metformin—polycystic ovary syndrome	0.00239	0.00702	CcSEcCtD
Capecitabine—Tremor—Metformin—polycystic ovary syndrome	0.00237	0.00698	CcSEcCtD
Capecitabine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00235	0.00691	CcSEcCtD
Capecitabine—Malaise—Metformin—polycystic ovary syndrome	0.00229	0.00672	CcSEcCtD
Capecitabine—Syncope—Metformin—polycystic ovary syndrome	0.00227	0.00668	CcSEcCtD
Capecitabine—Palpitations—Metformin—polycystic ovary syndrome	0.00224	0.00659	CcSEcCtD
Capecitabine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00223	0.00655	CcSEcCtD
Capecitabine—Hypertension—Metformin—polycystic ovary syndrome	0.00219	0.00643	CcSEcCtD
Capecitabine—Chest pain—Metformin—polycystic ovary syndrome	0.00216	0.00634	CcSEcCtD
Capecitabine—Myalgia—Metformin—polycystic ovary syndrome	0.00216	0.00634	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00214	0.0063	CcSEcCtD
Capecitabine—Discomfort—Metformin—polycystic ovary syndrome	0.00213	0.00627	CcSEcCtD
Capecitabine—Oedema—Metformin—polycystic ovary syndrome	0.00207	0.00608	CcSEcCtD
Capecitabine—Infection—Metformin—polycystic ovary syndrome	0.00205	0.00604	CcSEcCtD
Capecitabine—Shock—Metformin—polycystic ovary syndrome	0.00203	0.00598	CcSEcCtD
Capecitabine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00203	0.00596	CcSEcCtD
Capecitabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00202	0.00596	CcSEcCtD
Capecitabine—Skin disorder—Metformin—polycystic ovary syndrome	0.00201	0.00591	CcSEcCtD
Capecitabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.002	0.00588	CcSEcCtD
Capecitabine—Anorexia—Metformin—polycystic ovary syndrome	0.00197	0.0058	CcSEcCtD
Capecitabine—Hypotension—Metformin—polycystic ovary syndrome	0.00193	0.00568	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00188	0.00554	CcSEcCtD
Capecitabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00186	0.00546	CcSEcCtD
Capecitabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00184	0.00542	CcSEcCtD
Capecitabine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00182	0.00535	CcSEcCtD
Capecitabine—Decreased appetite—Metformin—polycystic ovary syndrome	0.0018	0.00529	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00179	0.00525	CcSEcCtD
Capecitabine—Fatigue—Metformin—polycystic ovary syndrome	0.00178	0.00524	CcSEcCtD
Capecitabine—Constipation—Metformin—polycystic ovary syndrome	0.00177	0.0052	CcSEcCtD
Capecitabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0017	0.00501	CcSEcCtD
Capecitabine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00169	0.00497	CcSEcCtD
Capecitabine—Urticaria—Metformin—polycystic ovary syndrome	0.00164	0.00483	CcSEcCtD
Capecitabine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00163	0.00481	CcSEcCtD
Capecitabine—Asthenia—Metformin—polycystic ovary syndrome	0.00148	0.00436	CcSEcCtD
Capecitabine—DPYD—Metabolism—LPCAT2—polycystic ovary syndrome	0.00148	0.00412	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SUOX—polycystic ovary syndrome	0.00148	0.00412	CbGpPWpGaD
Capecitabine—Pruritus—Metformin—polycystic ovary syndrome	0.00146	0.0043	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00145	0.00405	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NMNAT3—polycystic ovary syndrome	0.00144	0.00402	CbGpPWpGaD
Capecitabine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00141	0.00416	CcSEcCtD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00141	0.00394	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00138	0.00385	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ISYNA1—polycystic ovary syndrome	0.00137	0.00383	CbGpPWpGaD
Capecitabine—Dizziness—Metformin—polycystic ovary syndrome	0.00137	0.00402	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CCNB1—polycystic ovary syndrome	0.00135	0.00376	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LPCAT2—polycystic ovary syndrome	0.00132	0.00367	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SUOX—polycystic ovary syndrome	0.00132	0.00367	CbGpPWpGaD
Capecitabine—Vomiting—Metformin—polycystic ovary syndrome	0.00131	0.00387	CcSEcCtD
Capecitabine—Rash—Metformin—polycystic ovary syndrome	0.0013	0.00384	CcSEcCtD
Capecitabine—Dermatitis—Metformin—polycystic ovary syndrome	0.0013	0.00383	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.0013	0.00364	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.0013	0.00364	CbGpPWpGaD
Capecitabine—Headache—Metformin—polycystic ovary syndrome	0.0013	0.00381	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.00126	0.00352	CbGpPWpGaD
Capecitabine—Nausea—Metformin—polycystic ovary syndrome	0.00123	0.00361	CcSEcCtD
Capecitabine—CDA—Metabolism—ISYNA1—polycystic ovary syndrome	0.00122	0.00342	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKR1C2—polycystic ovary syndrome	0.00117	0.00326	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TEAD2—polycystic ovary syndrome	0.00117	0.00326	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RAB2A—polycystic ovary syndrome	0.00116	0.00325	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00115	0.00322	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NMNAT3—polycystic ovary syndrome	0.00115	0.00321	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—NRG1—polycystic ovary syndrome	0.00114	0.00318	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.00113	0.00317	CbGpPWpGaD
Capecitabine—CYP2C9—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00108	0.00301	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LPCAT2—polycystic ovary syndrome	0.00105	0.00294	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SUOX—polycystic ovary syndrome	0.00105	0.00294	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TEAD2—polycystic ovary syndrome	0.00104	0.0029	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKR1C2—polycystic ovary syndrome	0.00104	0.0029	CbGpPWpGaD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00104	0.0029	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00101	0.00282	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PNPLA2—polycystic ovary syndrome	0.000978	0.00273	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ISYNA1—polycystic ovary syndrome	0.000978	0.00273	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000954	0.00267	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SRD5A1—polycystic ovary syndrome	0.000927	0.00259	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.000916	0.00256	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000904	0.00253	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—STAR—polycystic ovary syndrome	0.000884	0.00247	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000871	0.00243	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000852	0.00238	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKR1C2—polycystic ovary syndrome	0.000831	0.00232	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TEAD2—polycystic ovary syndrome	0.000831	0.00232	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000826	0.00231	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000825	0.0023	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000825	0.0023	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000801	0.00224	CbGpPWpGaD
Capecitabine—CDA—Metabolism—STAR—polycystic ovary syndrome	0.000788	0.0022	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HMMR—polycystic ovary syndrome	0.000788	0.0022	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000755	0.00211	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HSD3B1—polycystic ovary syndrome	0.000752	0.0021	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00075	0.00209	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000748	0.00209	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000745	0.00208	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000742	0.00207	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000707	0.00197	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000703	0.00196	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HMMR—polycystic ovary syndrome	0.000702	0.00196	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000702	0.00196	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PNPLA2—polycystic ovary syndrome	0.000697	0.00195	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000692	0.00193	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—LHB—polycystic ovary syndrome	0.000686	0.00192	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HSD3B1—polycystic ovary syndrome	0.00067	0.00187	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HSD3B2—polycystic ovary syndrome	0.00067	0.00187	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000669	0.00187	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SRD5A1—polycystic ovary syndrome	0.00066	0.00184	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKR1C1—polycystic ovary syndrome	0.000649	0.00181	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000632	0.00177	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—STAR—polycystic ovary syndrome	0.00063	0.00176	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDC6—polycystic ovary syndrome	0.000629	0.00176	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000623	0.00174	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000612	0.00171	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LHB—polycystic ovary syndrome	0.000611	0.00171	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000597	0.00167	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SULT2A1—polycystic ovary syndrome	0.000597	0.00167	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NMNAT3—polycystic ovary syndrome	0.000588	0.00164	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000578	0.00162	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—RRM2—polycystic ovary syndrome	0.000578	0.00162	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000569	0.00159	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMMR—polycystic ovary syndrome	0.000561	0.00157	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—YAP1—polycystic ovary syndrome	0.000558	0.00156	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000555	0.00155	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000549	0.00153	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000548	0.00153	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SUOX—polycystic ovary syndrome	0.000538	0.0015	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPCAT2—polycystic ovary syndrome	0.000538	0.0015	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HSD3B1—polycystic ovary syndrome	0.000536	0.0015	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NAMPT—polycystic ovary syndrome	0.000536	0.0015	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000533	0.00149	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000532	0.00149	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP11A1—polycystic ovary syndrome	0.000529	0.00148	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000518	0.00145	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000518	0.00145	CbGpPWpGaD
Capecitabine—CDA—Metabolism—RRM2—polycystic ovary syndrome	0.000515	0.00144	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000512	0.00143	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ISYNA1—polycystic ovary syndrome	0.0005	0.0014	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKR1C3—polycystic ovary syndrome	0.0005	0.0014	CbGpPWpGaD
Capecitabine—CDA—Metabolism—YAP1—polycystic ovary syndrome	0.000497	0.00139	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP17A1—polycystic ovary syndrome	0.000492	0.00137	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RRM2—polycystic ovary syndrome	0.000491	0.00137	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LHB—polycystic ovary syndrome	0.000488	0.00136	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000482	0.00135	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NAMPT—polycystic ovary syndrome	0.000477	0.00133	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HSD3B2—polycystic ovary syndrome	0.000477	0.00133	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000471	0.00132	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000463	0.00129	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKR1C1—polycystic ovary syndrome	0.000462	0.00129	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000462	0.00129	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00045	0.00126	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000448	0.00125	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000446	0.00125	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000445	0.00124	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000442	0.00123	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000441	0.00123	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000438	0.00122	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—LMNA—polycystic ovary syndrome	0.000431	0.0012	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SULT2A1—polycystic ovary syndrome	0.000426	0.00119	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TH—polycystic ovary syndrome	0.000426	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TEAD2—polycystic ovary syndrome	0.000425	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKR1C2—polycystic ovary syndrome	0.000425	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000416	0.00116	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC2A4—polycystic ovary syndrome	0.000414	0.00116	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000413	0.00115	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—RRM2—polycystic ovary syndrome	0.000412	0.00115	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000402	0.00112	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—YAP1—polycystic ovary syndrome	0.000397	0.00111	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000393	0.0011	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP19A1—polycystic ovary syndrome	0.000389	0.00109	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000385	0.00108	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NAMPT—polycystic ovary syndrome	0.000382	0.00107	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TH—polycystic ovary syndrome	0.000379	0.00106	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP11A1—polycystic ovary syndrome	0.000377	0.00105	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000372	0.00104	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000369	0.00103	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000367	0.00103	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000363	0.00101	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000362	0.00101	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PNPLA2—polycystic ovary syndrome	0.000356	0.000996	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKR1C3—polycystic ovary syndrome	0.000356	0.000994	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP17A1—polycystic ovary syndrome	0.00035	0.000979	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000348	0.000973	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GNAS—polycystic ovary syndrome	0.000347	0.000971	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000347	0.000969	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SRD5A1—polycystic ovary syndrome	0.000338	0.000944	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000334	0.000932	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NCOR1—polycystic ovary syndrome	0.000331	0.000925	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000325	0.000908	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—STAR—polycystic ovary syndrome	0.000322	0.0009	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000321	0.000896	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1A1—polycystic ovary syndrome	0.000314	0.000876	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNAS—polycystic ovary syndrome	0.00031	0.000865	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TH—polycystic ovary syndrome	0.000303	0.000847	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000303	0.000846	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000302	0.000844	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000298	0.000833	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NCOR1—polycystic ovary syndrome	0.000295	0.000824	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A4—polycystic ovary syndrome	0.000295	0.000824	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTHFR—polycystic ovary syndrome	0.000292	0.000817	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000288	0.000805	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMMR—polycystic ovary syndrome	0.000287	0.000802	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1A1—polycystic ovary syndrome	0.00028	0.000781	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP19A1—polycystic ovary syndrome	0.000277	0.000775	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000275	0.000769	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000275	0.000769	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSD3B1—polycystic ovary syndrome	0.000274	0.000766	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000271	0.000756	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—polycystic ovary syndrome	0.000261	0.000728	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LHB—polycystic ovary syndrome	0.00025	0.000698	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNAS—polycystic ovary syndrome	0.000248	0.000692	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSD3B2—polycystic ovary syndrome	0.000244	0.000682	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000239	0.000668	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARG—polycystic ovary syndrome	0.000237	0.000663	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKR1C1—polycystic ovary syndrome	0.000237	0.000661	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000236	0.000659	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NCOR1—polycystic ovary syndrome	0.000236	0.000659	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—POMC—polycystic ovary syndrome	0.000234	0.000653	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—INS—polycystic ovary syndrome	0.000233	0.00065	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000231	0.000644	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1A1—polycystic ovary syndrome	0.000224	0.000624	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000219	0.000611	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SULT2A1—polycystic ovary syndrome	0.000218	0.000608	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARG—polycystic ovary syndrome	0.000211	0.000591	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—RRM2—polycystic ovary syndrome	0.000211	0.000589	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000209	0.000583	CbGpPWpGaD
Capecitabine—CDA—Metabolism—POMC—polycystic ovary syndrome	0.000208	0.000582	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000582	CbGpPWpGaD
Capecitabine—CDA—Metabolism—INS—polycystic ovary syndrome	0.000207	0.000579	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—YAP1—polycystic ovary syndrome	0.000203	0.000568	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NAMPT—polycystic ovary syndrome	0.000195	0.000545	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP11A1—polycystic ovary syndrome	0.000193	0.000539	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000193	0.000538	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000191	0.000534	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00019	0.000531	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKR1C3—polycystic ovary syndrome	0.000182	0.000509	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP17A1—polycystic ovary syndrome	0.000179	0.000501	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000177	0.000495	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.00017	0.000474	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—polycystic ovary syndrome	0.000169	0.000472	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—POMC—polycystic ovary syndrome	0.000167	0.000466	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—INS—polycystic ovary syndrome	0.000166	0.000463	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000162	0.000452	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000158	0.000442	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TH—polycystic ovary syndrome	0.000155	0.000433	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000155	0.000433	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000155	0.000433	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000153	0.000428	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000151	0.000422	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000144	0.000403	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000144	0.000401	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000142	0.000396	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000141	0.000394	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000132	0.000367	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNAS—polycystic ovary syndrome	0.000127	0.000354	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000125	0.000349	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000123	0.000342	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000123	0.000342	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOR1—polycystic ovary syndrome	0.000121	0.000337	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000118	0.000329	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000116	0.000324	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.000319	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—polycystic ovary syndrome	0.000107	0.000298	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000103	0.000287	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.74e-05	0.000272	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.29e-05	0.00026	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.18e-05	0.000257	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—polycystic ovary syndrome	8.64e-05	0.000242	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—POMC—polycystic ovary syndrome	8.53e-05	0.000238	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—INS—polycystic ovary syndrome	8.48e-05	0.000237	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.28e-05	0.000231	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.9e-05	0.000221	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.81e-05	0.000218	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.4e-05	0.000207	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.2e-05	0.000201	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.04e-05	0.000197	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.82e-05	0.00019	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.27e-05	0.000175	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.08e-05	0.00017	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.86e-05	0.000164	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.63e-05	0.000157	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.59e-05	0.000156	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.56e-05	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.52e-05	0.000154	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.25e-05	0.000147	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.17e-05	0.000144	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.47e-05	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.35e-05	0.000122	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.09e-05	0.000114	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.65e-05	0.000102	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.48e-05	9.71e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.3e-05	9.21e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.07e-05	8.58e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.49e-05	6.96e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.46e-05	6.87e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.44e-05	6.83e-05	CbGpPWpGaD
